Back to Search
Start Over
First Report and Comparative Genomics Analysis of a bla OXA-244 -Harboring Escherichia coli Isolate Recovered in the American Continent.
- Source :
-
Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2019 Nov 13; Vol. 8 (4). Date of Electronic Publication: 2019 Nov 13. - Publication Year :
- 2019
-
Abstract
- The carbapenemase OXA-244 is a derivate of OXA-48, and its detection is very difficult in laboratories. Here, we report the identification and genomic analysis of an Escherichia coli isolate (28Eco12) harboring the bla <subscript>OXA-244</subscript> gene identified in Colombia, South America. The 28Eco12 isolate was identified during a retrospective study, and it was recovered from a patient treated in Colombia. The complete nucleotide sequence was established using the PacBio platform. A comparative genomics analysis with other bla <subscript>OXA-244</subscript> -harboring Escherichia coli strains was performed. The 28Eco12 isolate belonged to sequence type (ST) 38, and its genome was composed of two molecules, a chromosome of 5,343,367 bp and a plasmid of 92,027 bp, which belonged to the incompatibility group IncY and did not harbor resistance genes. The bla <subscript>OXA-244</subscript> gene was chromosomally encoded and mobilized by an ISR1-related Tn 6237 composite transposon. Notably, this transposon was inserted and located within a new genomic island. To our knowledge, this is the first report of a bla <subscript>OXA-244</subscript> -harboring Escherichia coli isolate in America. Our results suggest that the introduction of the OXA-244-producing E. coli isolate was through clonal expansion of the ST38 pandemic clone. Other isolates producing OXA-244 could be circulating silently in America.
Details
- Language :
- English
- ISSN :
- 2079-6382
- Volume :
- 8
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Antibiotics (Basel, Switzerland)
- Publication Type :
- Academic Journal
- Accession number :
- 31766210
- Full Text :
- https://doi.org/10.3390/antibiotics8040222